CD19 CAR T cells (CD45RA-depleted)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 CAR T cells (CD45RA-depleted), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma [Phase 1]